On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We received an updated WNV package insert; please note the manufacturer and license number has been ...